Neo-adjuvant chemotherapy in mucinous breast cancer: Is it of clinical added value?

被引：0
|
作者：
Granzier, R. [1 ,2 ,3 ]
Van Nijnatten, T. [2 ,3 ]
Engelen, S. [1 ]
De Munck, L. [4 ]
Siesling, S. [4 ,5 ]
Smidt, M. [1 ,2 ]
机构：
[1] Maastricht Univ, Med Ctr, Surg, Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Radiol & Nucl Med, Maastricht, Netherlands
[4] Netherlands Comprehens Canc Org, Res, Utrecht, Netherlands
[5] Univ Twente, Dept Hlth Technol & Serv Res, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
355 (PB-15
引用
收藏
页码：S99 / S100
页数：2
相关论文
共 50 条
  • [31] Prediction and assessment of response to neo-adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists
    Masood, Shahla
    BREAST JOURNAL, 2021, 27 (08): : 629 - 630
  • [32] INFLAMMATORY BREAST-CANCER - NEO-ADJUVANT CHEMOTHERAPY WITH VINDESINE, ADRIAMYCINE AND CYCLOPHOSPHAMIDE
    CHEVALLIER, B
    BARRAL, D
    GENOT, JY
    GOUDIER, MJ
    KERBRAT, P
    GEDOIN, D
    MORICE, MF
    MALHAIRE, JP
    BULLETIN DU CANCER, 1989, 76 (02) : 127 - 131
  • [33] Pretreatment breast cancer marking with metal coil before neo-adjuvant chemotherapy
    Nadeem, R
    Chagla, LS
    Thind, R
    Harris, O
    Desmond, S
    Sharma, H
    Flavin, A
    Audisio, RA
    BRITISH JOURNAL OF SURGERY, 2004, 91 : 77 - 77
  • [34] Exploring Decision-Making about Neo-adjuvant Chemotherapy for Breast Cancer
    Zdenkowski, Nicholas
    Butow, Phyllis
    Fewster, Sheryl
    Beckmore, Corinna
    Wells, Kathryn
    Forbes, John F.
    Boyle, Frances
    BREAST JOURNAL, 2016, 22 (01): : 133 - 134
  • [35] The impact of body composition change on neo-adjuvant chemotherapy for breast cancer patients
    Iwase, T.
    Sangai, T.
    Ishigami, E.
    Sakakibara, J.
    Fujisaki, K.
    Shiina, N.
    Fujimoto, H.
    Sakakibara, M.
    Nagashima, T.
    Miyazaki, M.
    BREAST, 2015, 24 : S106 - S107
  • [36] The role of staging imaging prior to neo-adjuvant chemotherapy (NACT) for breast cancer
    Muir, Duncan
    Gathani, Toral
    Dodwell, David
    Remoundos, Dennis
    BRITISH JOURNAL OF SURGERY, 2021, 108 : 46 - 46
  • [37] Homologous recombination deficiency in breast cancer and association with response to neo-adjuvant chemotherapy
    Lips, E. H.
    Mulder, L.
    Hannemann, J.
    Peeters, M. J. Vrancken
    van de Vijver, M. J.
    Wesseling, J.
    Nederlof, P. M.
    Rodenhuis, S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 60 - 61
  • [38] Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy
    Taourel, P.
    Pages, E.
    Millet, I.
    Bourgier, C.
    Rouanet, P.
    Jacot, W.
    Crochet, P.
    Azria, D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 132 : 51 - 65
  • [39] Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer
    Stell, Virginia H.
    Flippo-Morton, Teresa S.
    Norton, H. James
    White, Richard L., Jr.
    BREAST JOURNAL, 2011, 17 (01): : 71 - 74
  • [40] Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
    Bhattacharyya, G. S.
    Walia, M.
    Nandi, M.
    Murli, A.
    Salim, S.
    Rajpurohit, S.
    Shinde, S.
    Aggarwal, S.
    Parikh, P. M.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (02) : 156 - 158
12345